Sara Cingarlini

18.1k total citations
65 papers, 1.8k citations indexed

About

Sara Cingarlini is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Sara Cingarlini has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 33 papers in Epidemiology and 14 papers in Neurology. Recurrent topics in Sara Cingarlini's work include Neuroendocrine Tumor Research Advances (33 papers), Lung Cancer Research Studies (24 papers) and Pancreatic and Hepatic Oncology Research (19 papers). Sara Cingarlini is often cited by papers focused on Neuroendocrine Tumor Research Advances (33 papers), Lung Cancer Research Studies (24 papers) and Pancreatic and Hepatic Oncology Research (19 papers). Sara Cingarlini collaborates with scholars based in Italy, United States and Canada. Sara Cingarlini's co-authors include Paola Zanovello, Vincenzo Bronte, Aldo Scarpa, Ilaria Marigo, Carmela De Santo, Paolo Serafini, Luigi Dolcetti, Giovanna Gallina, Marco Colombatti and Giovanni Butturini and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Sara Cingarlini

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Cingarlini Italy 24 1.1k 638 479 348 319 65 1.8k
Ariel E. Marciscano United States 16 1.3k 1.2× 287 0.4× 817 1.7× 371 1.1× 562 1.8× 53 2.1k
Marleen Melis Netherlands 27 904 0.8× 750 1.2× 454 0.9× 451 1.3× 290 0.9× 42 2.3k
Frank Hartmann Germany 25 910 0.8× 288 0.5× 385 0.8× 561 1.6× 233 0.7× 82 2.8k
Nikolaos E. Bechrakis Germany 32 793 0.7× 254 0.4× 326 0.7× 764 2.2× 299 0.9× 220 3.5k
Christof M. Kramm Germany 31 505 0.5× 407 0.6× 246 0.5× 909 2.6× 555 1.7× 100 2.6k
R Rampling United Kingdom 23 810 0.7× 581 0.9× 151 0.3× 778 2.2× 372 1.2× 49 2.7k
Arthur H. Tatum United States 24 448 0.4× 234 0.4× 298 0.6× 433 1.2× 280 0.9× 50 1.7k
Lauren A. Dalvin United States 24 593 0.5× 159 0.2× 164 0.3× 408 1.2× 234 0.7× 152 2.0k
P A Bunn United States 14 1.1k 1.0× 372 0.6× 295 0.6× 478 1.4× 459 1.4× 21 1.7k
Mandeep S. Sagoo United Kingdom 26 514 0.5× 387 0.6× 102 0.2× 429 1.2× 194 0.6× 148 2.5k

Countries citing papers authored by Sara Cingarlini

Since Specialization
Citations

This map shows the geographic impact of Sara Cingarlini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Cingarlini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Cingarlini more than expected).

Fields of papers citing papers by Sara Cingarlini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Cingarlini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Cingarlini. The network helps show where Sara Cingarlini may publish in the future.

Co-authorship network of co-authors of Sara Cingarlini

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Cingarlini. A scholar is included among the top collaborators of Sara Cingarlini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Cingarlini. Sara Cingarlini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strosberg, Jonathan, Rachel P. Riechelmann, Jorge Hernando, et al.. (2025). Efficacy of immune checkpoint inhibitors in patients with advanced pancreatic NETs displaying high TMB and MMR alterations following treatment with alkylating agents.. Journal of Clinical Oncology. 43(4_suppl). 662–662. 2 indexed citations
3.
Fracasso, Giulio, Elisabetta Falvo, Gianluca Sala, et al.. (2023). Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers. Heliyon. 9(10). e20770–e20770. 4 indexed citations
4.
Mafficini, Andrea, Lodewijk A.A. Brosens, Maria Liliana Piredda, et al.. (2022). Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants. Familial Cancer. 21(4). 441–451. 4 indexed citations
5.
Luchini, Claudio, Rita T. Lawlor, Samantha Bersani, et al.. (2021). Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?. Current Oncology Reports. 23(9). 106–106. 22 indexed citations
6.
Fernandes, Eduardo, et al.. (2021). Laparoscopic intragastric resection of gastric synovial sarcoma: report of the first ever case with video demonstration. World Journal of Surgical Oncology. 19(1). 65–65. 3 indexed citations
7.
Paiella, Salvatore, Luca Landoni, Matteo Salgarello, et al.. (2021). Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases. Neuroendocrinology. 112(2). 143–152. 26 indexed citations
8.
Robertis, Riccardo De, Chiara Longo, Sara Cingarlini, et al.. (2020). Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake. Cancers. 12(6). 1486–1486. 9 indexed citations
9.
D’Onofrio, Mirko, Nicolò Cardobi, Riccardo De Robertis, et al.. (2019). CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms. Scientific Reports. 9(1). 2176–2176. 56 indexed citations
10.
Barresi, Valeria, Michele Simbolo, Andrea Mafficini, et al.. (2019). Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment. Cancers. 11(9). 1279–1279. 23 indexed citations
11.
Simbolo, Michele, Caterina Vicentini, Andrea Mafficini, et al.. (2018). Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 473(6). 709–717. 37 indexed citations
12.
Robertis, Riccardo De, Bogdan Maris, Nicolò Cardobi, et al.. (2018). Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?. European Radiology. 28(6). 2582–2591. 67 indexed citations
13.
D’Onofrio, Mirko, Sara Cingarlini, Silvia Ortolani, et al.. (2017). Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment. Anticancer Research. 37(3). 1305–1312. 9 indexed citations
14.
Cingarlini, Sara, Silvia Ortolani, Matteo Salgarello, et al.. (2016). Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors. Pancreas. 46(1). 42–47. 32 indexed citations
15.
Bonomi, Maria, Sara Pilotto, Michèle Milella, et al.. (2011). Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research. Journal of Experimental & Clinical Cancer Research. 30(1). 115–115. 25 indexed citations
16.
Colombatti, Marco, Silvia Grasso, Alessandra Porzia, et al.. (2009). The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1. PLoS ONE. 4(2). e4608–e4608. 89 indexed citations
17.
Fracasso, Giulio, et al.. (2005). Apical Transport and Folding of Prostate-specific Membrane Antigen Occurs Independent of Glycan Processing. Journal of Biological Chemistry. 281(6). 3505–3512. 11 indexed citations
18.
Palma, Raffaele De, Ilaria Marigo, Francesco Del Galdo, et al.. (2004). Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8+ T Lymphocytes. Cancer Research. 64(21). 8068–8076. 21 indexed citations
19.
Bronte, Vincenzo, Sara Cingarlini, Elisa Apolloni, et al.. (2003). Effective Genetic Vaccination with a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation during Tumor Rejection Phase. The Journal of Immunology. 171(12). 6396–6405. 33 indexed citations
20.
Serafini, Paolo, Carmela De Santo, Ilaria Marigo, et al.. (2003). Derangement of immune responses by myeloid suppressor cells. Cancer Immunology Immunotherapy. 53(2). 64–72. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026